Sagespring Wealth Partners’s Boston Scientific BSX Stock Holding History

Sagespring Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Sell	10,023 -2,895	-22%	-$157K	0.01%	569
2026 Q1	$811K	Sell	12,918 -606	-4%	-$48.5K	0.01%	377
2025 Q4	$1.29M	Sell	13,524 -2,277	-14%	-$223K	0.02%	260
2025 Q3	$1.54M	Buy	15,801 +2,965	+23%	+$307K	0.03%	224
2025 Q2	$1.38M	Buy	12,836 +1,230	+11%	+$124K	0.03%	223
2025 Q1	$1.17M	Buy	11,606 +1,431	+14%	+$144K	0.03%	221
2024 Q4	$909K	Buy	+10,175	New	+$896K	0.02%	237

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sagespring Wealth Partners's BSX Position: Q2 2026 in Review

Sagespring Wealth Partners reduced its Boston Scientific (BSX) stake by 22% in Q2 2026, selling an estimated $157K and leaving 10,023 shares worth $428K. The position accounts for 0.01% of the portfolio, ranked #569.

Sagespring Wealth Partners first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.54M in Q3 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Sagespring Wealth Partners held 10,023 shares of Boston Scientific worth $428K as of Q2 2026.
Sagespring Wealth Partners sold 2,895 Boston Scientific shares in Q2 2026, an estimated $157K.
Boston Scientific made up 0.01% of Sagespring Wealth Partners's portfolio in Q2 2026, its #569 holding.
Sagespring Wealth Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
Sagespring Wealth Partners's Boston Scientific position peaked at $1.54M in Q3 2025.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.